Relapse Risk Assessment for Schizophrenia Patients (RASP): A New Self-Report Screening Tool

Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), Charles Ruetsch(University of Maryland, Baltimore), Heidi C. Waters(University of Maryland, Baltimore), William T. Carpenter(University of Maryland, Baltimore), Susan N. Legacy(Otsuka Pharmaceutical (Spain)), Nicole Gerlanc(Murray State University)
Clinical Schizophrenia & Related Psychoses
November 22, 2017
Cited by 2


Related Papers